Nanomedicine Market by by Product (Therapeutics, Regenerative Medicine), Industry Forecast, 2014-2022
The global nanomedicines market is driven by increase in prevalence of chronic disorders, presence of high, unmet medical needs (especially in developing countries), and increase in government funding for nanomedicines. However, lack of organized regulatory standards restrains the market growth. The growth opportunities in the emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for market growth during the forecast period.
View full press release